(Q72667440)
Statements
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines (English)
B V Bapat
J A Parker
T Berk
Z Cohen
R S McLeod
P N Ray
1 February 1994